diagnostics

The U.S. Food and Drug Administration (FDA) has cleared for marketing an innovative blood test with underlying technology invented at Washington University School of Medicine in St. Louis for the early diagnosis of Alzheimer's disease.

The FDA has cleared a blood test developed from technology invented at WashU Medicine to aid in diagnosing Alzheimer's disease. The test, PrecivityAD2, can detect amyloid plaque biomarkers with over 90% accuracy, offering a less invasive alternative to spinal taps and brain scans.

Scientific Reports, Published online: 22 August 2026; doi:10.1038/s41598-026-67932-w Machine learning incorporating trabecular bone score improves lumbar fracture risk stratification in type 2 diabetes

Scientific Reports, Published online: 22 August 2026; doi:10.1038/s41598-026-68106-4 Multi-label arrhythmia classification from Holter scatter plots using deep learning and clinically oriented thresholds

A new system can generate blood pressure readings nearly as well as the invasive and risky arterial lines relied on in ICUs and operating rooms.

Background and PurposeInvestigating the assessment of innovative serum indicators with elevated sensitivity and specificity is crucial for enhancing the early diagnosis and prognosis of HCC (Hepatocellular carcinoma). This study aimed to evaluate the efficacy of COPA (Coatomer Subunit Alpha) in diagnosing hepatocellular carcinoma and assessing the effectiveness of immunotherapy.MethodsThis study …

Researchers at Washington University in St. Louis have developed a technique that researchers and clinicians can use to assess the reliability of medical imaging tools. The new method also may be useful for regulators who evaluate new AI-backed medical imaging tools as they come to market.

Researchers at Washington University in St. Louis have developed a technique that researchers and clinicians can use to assess the reliability of medical imaging tools. The new method also may be useful for regulators who evaluate new AI-backed medical imaging tools as they come to market.

FRIDAY, Aug. 21, 2026 — The next time you roll up your sleeve for a blood test, the hand holding the needle may not be a hand at all.Federal regulators have authorized the first robot capable of drawing blood from a patient's arm on its own, with...

A sound wave–based therapy commonly used to dislodge kidney stones is gaining traction as a treatment for erectile dysfunction.

From headaches to vision changes, these are the potential signs to watch out for

Doctors in the UK have tested a new 20-minute treatment that could offer some people with high blood pressure an alternative to surgery. The procedure targets tiny growths in the adrenal glands that can cause blood pressure to rise. The research, involving Queen Mary University of London, Barts Health NHS Trust, University College London and […] The post 20-Minute Treatment Could Cure Some High B…

Overview The Global Nucleic Acid Amplification Testing Market size is expected to be worth around US$ 26.3 Billion by 2034, from US$ 9.7 Billion in 2024, growing at a CAGR of 10.5% during the forecast period from 2025 to 2034. North America held a dominant market position, capturing more than a 39.4% share and holds US$ 3.8 Billion market value for the year. Nucleic Acid Amplification Testing (NA…